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Spinal Infections: From Prevention to Cure
Thoracic Epidural Abscesses: A Systematic
Review
Benjamin A. Howie, BA, MPH1,2 , Iyooh U. Davidson, MD1,
Joseph E. Tanenbaum, BA1,3, Markian A. Pahuta, MD4,
Avery L. Buchholz, MD, MPH5, Michael P. Steinmetz, MD1,
and Thomas E. Mroz, MD1,3
Abstract
Study Design: Systematic review.
Objectives: Past research has demonstrated increased speed and severity of progression for spinal epidural abscesses (SEAs) of the
thoracic level, specifically, when compared with SEAs of other spinal cord levels. Untreated, this infection can result in permanent
neurological sequelae with eventual progression to death if inadequately managed. Despite the seriousness of this disease, no articles
have focused on the presentation, diagnosis, and treatment of SEAs of the thoracic level. For this reason, specific focus on SEAs of the
thoracic level occurred when researchers designed and implemented the following systematic review.
Methods: A query of Ovid-Medline and EMBASE, Cochrane Central, and additional review sources was conducted. Search
criteria focused on articles specific to thoracic epidural abscesses.
Results: Twenty-five articles met inclusion criteria. The most commonly reported symptoms present on admission included back
pain, paraparesis/paraplegia, fever, and loss of bowel/bladder control. Significant risk factors included diabetes, intravenous drug
use, and advanced age (P ¼ .001). Patients were most often treated surgically with either laminectomy, hemilaminectomy, or
radical decompression with debridement. Patients who presented with neurological deficits and had delayed surgical intervention
following a failed antibiotic course tended to do worse compared with their immediate surgical management counterparts
(P < .005).
Conclusions: For the first time researchers have focused specifically on SEAs of the thoracic level, as opposed to previously
published general analysis of SEAs as a whole. Based on the results, investigators recommend early magnetic resonance imaging of
the spine, laboratory workup (sedimentation rate/C-reactive protein, complete blood count), abscess culture followed by empiric
antibiotics, and immediate surgical decompression when neurological deficits are present.
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Introduction
Spinal epidural abscess (SEA) is a potentially life-threatening
medical emergency that often warrants immediate medical
(antibiotic) and/or surgical intervention.1 SEAs develop
through either direct spread from a contiguous site (vertebral
osteomyelitis, overlying cellulitis, epidural injection)2 or via
hematogeneous seeding of the epidural space often seen in
intravenous drug users, septic patients, or patients with general-
ized bacteremia.3,4 SEAs can progress rapidly and have the
potential to cause irreversible neurological deficits when
treatment is delayed.5-8 A recent study conducted by the
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Department of Veterans Affairs found that 55% (n ¼ 66) of all
SEA cases were initially misdiagnosed. Time to correct diag-
nosis was 12 days in patients initially misdiagnosed, versus 4
days for patients properly diagnosed (P < .01).9 Misdiagnosis
in this study was most often the result of inadequate recognition
of “red flag” signs (unexplained fever, progressive neurologi-
cal deficits, active infection) and inadequate initial evaluation
as performed by the treating physician (n ¼ 60; 90.1%).
Prior research on clinical manifestations and disease pro-
gression of SEAs found significant differences across spinal
cord regions (cervical vs thoracic vs lumbar).10-13 Khanna
et al previously described more rapid and severe onset of neu-
rological deficit in patients with cervical and thoracic SEAs
relative to patients with lumbar SEA.14 One possible explana-
tion of this finding is that the smaller canal diameters in the
thoracic spinal cord lead to more severe early compression of
the spinal cord in the thoracic spine compared with the lumbar
spine. In support of this theory, several studies have previously
reported patients with SEAs of the thoracic spine presented
more abruptly and with more severe neurological deficits when
compared with similar patients with SEAs located in more
caudal spinal cord levels.15-17
Logical organization of information surrounding thoracic
SEAs from a spine surgeon’s perspective would ideally include
the following components: (1) patient symptomology (typical
signs and symptoms); (2) the clinical approach and diagnostic
workup; (3) treatment failure and risk factors for failure of
medical management (pharmacotherapy alone); (4) neurologi-
cal recovery rates and effect of medical management versus
surgical treatment, specifically, in relation to time to treatment;
and (5) Indications for stabilization in patients presenting with
thoracic SEAs. With this in mind, investigators are limited by
the existing body of evidence as it relates to thoracic SEAs
rather than SEAs of all spinal cord levels in general. Organi-
zation of information extracted depends heavily on the current
research landscape.
Despite prior research indicating that thoracic SEAs expand
and compress important spinal cord structures earlier than SEAs
at other levels, there is a gap in the literature about optimal
management of thoracic SEAs. For this reason, the present study
focused on synthesizing the available evidence regarding clinical
manifestations, natural history, and management of thoracic
SEAs with the aim of reducing morbidity and mortality associ-
ated with misdiagnosis or delayed treatment.9,14
Methods
Search Strategy
Investigators conducted a search review of 3 databases—
Medline, Embase, and Cochrane Central—with the follow-
ing search term strategy: (“Epidural Abscess” OR “SEA”)
AND (“Thoracic” OR “Thoracic Vertebrae”). Subsequent
review of other literature sources (Google Scholar, PubMed)
employed a similar search strategy (key terms: “Epidural
Abscess” or “SEA” AND “Thoracic” OR “Thoracic
Vertebrae”). In total, 693 articles were identified from the
database and outside source search (Figure 1). The search
period ended June 28, 2017.
Inclusion and Exclusion Criteria
Articles were included if they reported results relating to epi-
dural abscess of the thoracic spine. Retrospective cohort stud-
ies, prospective cohort studies, and clinical trials were the only
study types included due to their superior quality of evidence
when compared with case reports or expert advice.18 Case
reports were excluded from the current study.
Articles that did not stratify results by spinal cord region
(cervical, thoracic, or lumbosacral) and articles that focused on
spondylitis or spondylodiscitis or infection of the spinal cord in
general without focus on epidural abscess of the thoracic spine
were excluded.
Data Collection
Two trained reviewers (BH and ID) independently reviewed
each study at each of the 4 stages described below. At each of
the 4 stages, a third author (JT) acted as final arbiter when
inclusion and exclusion disagreements arose. First, duplicates
from the 693 articles were deleted and the remaining article
titles were screened for inclusion. Second, among those studies
that were included following the title review, full abstracts
were read and inclusion and exclusion criteria were again
reviewed. Third, after studies were included following abstract
review, the full manuscript was reviewed and a final decision
of inclusion or exclusion was made. Data extraction of the final
sample of articles involved independent review of each article
by 2 trained reviewers (BH and ID). Included articles were
assessed for level of evidence based on the Oxford Center for
Evidence Based Medicine (OCEBM) evaluation criteria.19
Results
Of the 693 articles obtained from the initial search, 480
remained after 213 duplicates were removed. An additional
452 articles were removed following the initial title review,
and the resultant 27 remaining articles were screened based
on abstract content alone. After this review, 2 additional arti-
cles were excluded following independent review of the full
text content. In total, 25 articles (see the appendix) were
included in the final analysis based on the aforementioned data
collection methodology (Figure 1). Of the 25 articles, 24 arti-
cles were retrospective reviews and 1 was a prospective cohort.
Articles were published between 1990 and 2017. Based on
recurring themes found throughout included articles, our find-
ings were separated into 5 categories: (1) clinical presentation,
duration of symptoms, and risk factors; (2) radiological, micro-
biology, and laboratory findings; (3) pharmacological manage-
ment; (4) surgical management; and (5) patient outcomes.
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Clinical Presentation, Duration of Symptoms, and Risk
Factors
Of the 25 included articles, 22 (88%) provided case informa-
tion on presenting symptoms, clinical progression, and risk
factors associated with development of thoracic SEA prior to
hospital admission (Table 1). Back pain (n ¼ 16; 64%),3,12,20-33
neurological deficits (n ¼ 17; 68%),3,12,20-30,32-35 including
paraparesis (n ¼ 12; 48%)3,20,22,24,26,28-30,33-36 and paraplegia
(n ¼ 5; 20%),22,24,28,34,35 fever (n ¼ 6; 24%),3,21,23,24,26,29
and loss of bowel or bladder control (n ¼ 4; 16%)22,25,26,34
were among the most commonly reported symptoms present
at time of admission.
Clinical progression and time to admission following onset
of symptoms was variable, but largely underreported by inves-
tigators. Of the 3 studies that did report clinical progression
from onset of symptoms to follow-up after surgery, 2 studies
documented the presence of pain occurring first followed by
progression to concomitant pain with neurological deficits
(8%).25,35 Hadjipavlou et al noted that back pain generally
preceded the onset of neurological deficits.35 Kuker et al
reported a similar pattern of preceding back pain prior to the
onset of neurological deficits in patients diagnosed with thor-
acic SAE. However, in their study the lag between pain and
neurological symptoms was highly variable (median:
2.7 months).25 According to Bostro¨m et al, patients waited
between 12 hours to several months from time of symptom
onset (back pain, weakness, neurological dysfunction) to pres-
ent for medical treatment of thoracic epidural abscess.32
Risk factors for developing thoracic SEA can be divided
into either modifiable or nonmodifiable risk factors. Among
the modifiable risk factors, alcoholism and intravenous drug
use were most strongly associated with thoracic SEAs.3,12,21,32
Bacteremia caused by nonsterile injection needles was the most
commonly identified preventable risk factor (n ¼ 3; 12%).
However, thoracic SEA has been observed after lumbar epi-
dural steroid injections as well.37
Figure 1. Thoracic SEA systematic review PRISMA flow chart.
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Table 1. Clinical Presentation and Duration of Symptoms.
Author (Year
Published) Presenting Symptoms
Duration of Symptoms Prior to
Admission Risk Factors
Abdelrahman et al
(2017)
Neurological deficit (ASIA A-D) present
in 51.2%
— Overall recovery for patients with
paraparesis/paraplegia after epidural
abscess was 20% for all levels. No
patients with paraparesis/paraplegia
from thoracic abscess recovered versus
50% recovery in lumbar epidural
abscess. Incidence increase with age
(P ¼ .001): 54.5% older than 60 (P ¼
.003); 57.4% over 80 years old due to
immunosuppression and
immunocompromised.
Aryan et al (2007) Both presented with myelopathy — —
Bostro¨m et al (2008) Frankel A in 5; B in 3; C in 6; E in 3; back
pain present in all
12 hours to several months Diabetes mellitus (n ¼ 4), alcoholism
(n ¼ 4), immunosuppression (n ¼ 4),
malignancy (n ¼ 3), peridural catheter
(n ¼ 3), intravenous (IV) drug abuse
(n ¼ 2), previous spinal operation (n ¼
2), and infections at other locations
(n ¼ 6)
Chen et al (2004) Most frequently presented with back
and/or neck pain; motor deficits were
the most common presenting sign
— Diabetes mellitus (DM), chronic renal
failure (CRF), alcoholism, liver cirrhosis
Christodoulou et al
(2006)
All had persistent back pain; 4 presented
with paraparesis
— —
Connor et al (2013) Axial pain (67.5%), focal weakness
(55.8%), radiculopathy (29.9%), and
myelopathy (5.2%)
— —
Curry et al (2005) Fever, pain, and motor deficits were
present in the majority of cases
— Intravenous drug use most common risk
factor. Patients with spinal epidural
abscess may be normothermic with
normal WBC counts. Urgent surgery
was more likely to be offered to
patients presenting with neurologic
deficits than with pain alone.
Darouiche et al
(1992)
Backache (72%), radicular pain (47%),
weakness of an extremity (35%),
sensory deficit (23%), bladder or bowel
dysfunction (30%), and frank paralysis
(21%)
— —
Davda et al (2014) Back pain (100%), focal neurology (71%),
and constitutional symptoms (fevers þ
weight loss) (44%)
— —
de la Fuente Aguado
et al (1992)
Fever and vertebral pain were the most
constant clinical symptoms
— —
Del Curling et al
(1990)
Paraplegia and bladder dysfunction (43%),
paraparesis (43%), and no presenting
symptoms (14%)
— Diabetes, acquired immunodeficiency
syndrome (AIDs), sepsis
Furey et al (2014) — — Significant risk factors for mortality: age
>70 years (P ¼ .02), hospitalization
>5 days prior to surgery (P ¼ .04),
American Spinal Injury Association
(ASIA) D (P ¼ .01), DM (P ¼ .01),
methicillin-resistant S aureus (MRSA)
sepsis (P ¼ .03), and end-stage renal
disease (ESRD; P ¼ .02). Significant
factors for neurologic Significant risk
(continued)
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Reported nonmodifiable risk factors included immunosup-
pression (n ¼ 5; 20%),26,27,35-37 advanced age (n ¼ 5;
20%),25,26,32,34,36 liver cirrhosis (n¼ 2; 8%),33,38 chronic kidney
failure (n ¼ 4; 16%),12,26,37,38 and AIDS (n ¼ 2; 8%).27,35 His-
tory of diabetes mellitus was also reported as a risk factor for the
development of thoracic SEA (n ¼ 7; 28%).27,28,33,35,36,38
Radiographic, Microbiology, and Laboratory Findings
Diagnosis and monitoring (imaging and laboratory testing) for
treatment response was described in 23 of the included articles
(92%; Table 2). Use of imaging modalities (magnetic
resonance imaging [MRI], computed tomography [CT],
X-ray [XR]) was reported in 8 of these articles (32%):
MRI,22,24,26,27,31,39,40 CT,25,27,40 and XR29 imaging were noted
in 6, 3, and 1 of the articles that met inclusion criteria, respec-
tively. Curry et al demonstrated the utility of MRI with gado-
linium contrast (71%) and CT myelography (29%) in the
diagnosis of thoracic SEA among cases subsequently diag-
nosed with thoracic SEA at time of surgery.21 Kuker et al fur-
ther supported the utility of MRI with gadolinium in the
conformation of thoracic SEA and went on to suggest that
signal changes in T2-weighted images may be among the first
signs of disc space infection.25 Other diagnostic modalities
Table 1. (continued)
Author (Year
Published) Presenting Symptoms
Duration of Symptoms Prior to
Admission Risk Factors
factors for improvement: age <70 years
(P ¼ .01), neurologic deterioration less
than 24 hours (P¼ .01), lumbar abscess
not requiring fusion (P ¼ .02),
preoperative ASIA B or C (P ¼ .01),
and nondiabetics (P ¼ .02)
Hadjipavlou et al
(2000)
Paraplegia or paraparesis (100%) Back pain generally preceded
onset of neurological deficit
Infection in other body site most
common. Epidural abscess of the
thoracic spine had the highest
incidence of paraplegia/paraparesis
(P < .001). Thecal sac
neurocompression has a greater
chance of causing neurologic deficit in
the thoracic spine (81.8%)
Kuker et al (1997) Progressive sensorimotor deficits with
back pain most common; urinary
retention or loss of rectal sphincter
control was a common presenting
motor deficit
Pain preceded neurological
deficits by median 2.7 months;
pain occurred around same
time neurological deficits
Pulmonary tuberculosis (TB),
immunocompromised state
Lee et al (2011) — — Local epidural injection for pain, DM, ESRD/
chronic renal disease, liver cirrhosis
Liem et al (1994) Back pain (90%), paresthesia (29%),
incontinence (38%), fever with body
temperature >101F (29%), and/or
severe (less than antigravity strength
(71%)), moderate (10%) motor deficits,
and no deficits (19%)
— IV drug use (33%), DM (19%), prior
surgery (14%), endocarditis (10%), HIV
(10%), ESRD (10%), epidural
catheterization (5%)
Nakase et al (2006) Myelopathy or radicular pain — —
Patel et al (2014) Pain and subjective fevers (50%) and/or
weakness (47%)
— IV drug use (39.1%), DM (21.9%)
Redekop et al (1992) Severe back pain progressing to radicular
pain to weakness to eventual paralysis
(100%)
— Thoracic cord anatomy (limited space)
was a risk factor for earliest and most
severe neurological deficits. Cellulitis
or cutaneous abscess, respiratory
infection, vertebral osteomyelitis.
Talia et al (2015) Back pain (100%), progressive kyphosis
(67%), fever (17%), limb weakness
(78%)
— —
Wang et al (2001) Inferior paraparesis and/or back pain — Epidural analgesia (100%). Thoracic level
was risk factor for poor paraparesis/
paraplegia recovery with most survivors
having poor recovery long term.
Wong et al (1998) New spinal or radicular pain — Early diagnosis was associated with a
better outcome
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utilized in the diagnostic process included myelography (n¼ 2;
8%)24,26 and plain film radiographs (n ¼ 1; 4%), although the
latter was less specific for epidural abscess within the thoracic
spine and more specific to purulent disc space infection.28
Seven studies reported the use of C-reactive protein (CRP)
and/or erythrocyte sedimentation rate (ESR) in SEA disease
identification and subsequent treatment response monitoring.
Bostro¨m et al defined an elevated CRP as greater than 5 mg/dL
with 78% of cases included in this study having a pretreatment
CRP value between 23 and 230 mg/dL. Authors did not spe-
cifically define ESR thresholds before and after treatment;
however, in the case of Kuker et al and Bostro¨m et al, the
authors noted that elevated readings were defined as values
above normal laboratory cutoff points (0-22 mm/hour for men
and 0-29 mm/hour for women).25,32 Similarly, Kuker et al
found that pretreatment CRP values were elevated in 100%
of reported cases.25 ESR was found to be consistently elevated
in patients presenting with thoracic epidural abscess as seen in
Kuker et al (100%), Hadjipavlou et al (100%), Liem et al
(100%), and Wong et al (100%). All reported elevation above
normal range for pretreatment ESR values.25,26,31,35 With the
exception of thoracic epidural abscesses caused by tuberculo-
sis, all investigators who monitored posttreatment CRP and
ESR levels reported a decrease to normal values (n ¼ 5;
19%).25-27,31,33 Christodoulou et al, Nakase et al, and Wong
et al reported the utilization of CRP and ESR monitoring in
assessing epidural abscess response to treatment. In their
respective reports all treated patients’ CRP and ESR levels
returned to normal with resolution of infection.27,31,33 Simi-
larly, increased white blood cell (WBC) counts with a return
to normal levels following treatment was reported by
Bostro¨m et al (48%), Hadjipavlou et al (90%), and Liem
et al (62%).26,32,35 Hadjipavlou et al reported concomitant
spondylodiscitis in one third of patients with thoracic SEA
(n ¼ 11/33; 33%).35
The most frequently reported causative bacteria was Staphy-
lococcus aureus (n¼ 18; 72%; Table 2).3,21,22,25-31,33-40 Abdel-
rahman et al found no age predilection for infection with S
aureus (P ¼ .074).36 Methicillin-sensitive S aureus (MSSA)
was the causative bacteria in nearly 30% of patients reported by
Curry et al and 40% of patients reported by Patel et al. Curry et
el also found methicillin-resistant S aureus (MRSA; 31%) to be
slightly more common than MSSA (30%) in patients admitted
for thoracic SEA; thus, abscess culture and sensitivity profiles
are necessary for effective treatment, as the pharmacological
therapy for MSSA is ineffective against MRSA.21 Less com-
monly reported bacterial strains cultured from thoracic epi-
dural abscess aspirates included S epidermidis,41 other
coagulase negative Staphylococcus species,32 gram negative
rods, Streptococcus agalactiae,25 and Streptococcus pyogenes
(Table 2).28
While Mycobacterium tuberculosis (TB) has a very differ-
ent bacterial lifecycle and spread relative to the other bacterial
strains previously discussed, 3 included articles focused on this
bacterial species as a cause of thoracic SEA.27,33,42 Research in
these studies found that these bacteria spread hematogeneously
to the thoracic epidural space, as opposed to the majority of
cases caused by S aureus that colonized the epidural space via
direct extension. Additionally, these studies demonstrated that
special aerobic culture on TB-specific media needed to be
undertaken for proper diagnosis of this offending organism,
as typical gram stain and culture would fail to diagnose the
acid-fast bacterial species.
Pharmacological Management
Pharmacological management of thoracic SEAs was described
in 13 of the included articles (52%). All 10 studies that reported
pre- and postoperative antibiotic choice indicated that therapy
was guided by sensitivity profiles obtained through bacterial
culture (n ¼ 10; 100%; Table 3).20,26,27,30,32,33,35,40-42 Pharma-
cotherapy failure was described in 2 of the articles. Curry et al
focused on the effect of failed medical management (pharma-
cotherapy) with subsequent delayed surgical treatment of epi-
dural abscess.22 Authors found that patients who received
antibiotics and failed to clear their infection had significantly
worse outcomes (ie, progression of neurological deterioration
or reduced improvement in neurological symptoms following
operation) compared with patients who received antibiotics and
immediate surgical treatment (P < .005).22 Patel et al identified
3 predictors of medical management failure: (1) CRP >115
(odds ratio [OR] 4.7, P ¼ .045), (2) WBC >12.5 (OR 3.3,
P ¼ .045), and (3) positive blood cultures (OR 3.5, P ¼
.035). Patients that did not have any of these risk factors at
time of therapy were predicted to have an 8.3% risk of failing
pharmacotherapy, whereas patients with 1 of 3, 2 of 3, or 3 of 3
of these risk factors were predicted to have a 35.4%, 40.2%,
and 76.9% pharmacotherapy failure risk, respectively.28
Surgical Management and Patient Outcomes
Surgical treatment of thoracic SEA was discussed in 16 of the
included articles (Table 4).3,20,24-27,29,30,33-35,37,38,40,42 Patient
outcomes following surgery were discussed in 15 of these arti-
cles.3,20,24-27,29,30,33-35,37,38,40 Results of the following surgical
techniques were reported in the included studies: laminectomy
(n¼ 10; 63%), hemilaminectomy (n¼ 2; 13%), decompression
and debridement/evacuation (n ¼ 7; 44%), corpectomy with
instrumentation (n ¼ 2; 13%), and continuous irrigation
through a laminotomy (n ¼ 1; 6%). Surgical technique was
based on the location of the SEA within the thoracic spine in
5 studies (31%), patient clinical status in 1 study (6%), and
preoperative laboratory and imaging findings in 3 studies
(19%). Seven articles discussed decision making criteria
(Table 5).3,20,27,32,35,38,42 In an earlier study by Wang et al, all
patients were treated surgically with laminectomy and antibio-
tics pre- and postoperatively for variable durations. Of the
9 patients being treated for thoracic SEA, 7 had paraparesis/
paraplegia at time of surgery and 6 did not recover following
laminectomy, with 5 patient deaths during the postoperative
follow-up period. Patients with severe preoperative motor dys-
function also had the most postoperative dysfunction with no
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Table 3. Pharmacological Management.
Author (Year Published) Antibiotic Therapy
Antibiotic
Duration Notes
Aryan et al (2007) IV antibiotics pre- and postoperatively based
on culture sensitivity
At least 6 weeks No recurrence of bone or hardware infection
among patients treated with antibiotics
Bostro¨m et al (2008) Clindamycin was drug of choice in majority of
Staphylococcus infections
— —
Christodoulou et al (2006) Antituberculous treatment preoperatively
and for up to 9 months postoperatively.
Regimen: streptomycin (1 g/day for
1 month and 1 g every alternate day for
1 month); rifampicin (600 mg/day for
9 months); isoniazid (300 mg/day for
9 months); and pyrazinamide (1.5 g/day for
2 months). Streptomycin and pyrazinamide
replaced after 2 months and switched by
ethambutol (1.2 g/day) for another 7
months.
9 months All patients began antituberculosis medication
preoperatively and liver and renal function
monitored regularly during therapy
Connor et al (2013) Tailored to bacterial sensitivity from cultures.
All had intravenous (IV) pre- and
postoperatively.
Median 6 weeks
(2-24 weeks)
—
Curry et al (2005) — — Patients who received antibiotics and had
delayed surgical management had
significantly more poor outcomes than
those treated early surgically (increased
morbidity and mortality) (P < .005)
Del Curling et al (1990) — Median 2 weeks IV
(1.5-6 weeks)
followed by oral
antibiotics
(0-6 weeks)
—
Hadjipavlou et al (2000) Clindamycin and ofloxacin were
predominantly used based on culture
sensitivities. If blood-brain barrier (BBB)
had suspected compromise use of
vancomycin and ceftazidime was initiated.
— —
Liem et al (1994) Tailored to bacterial sensitivity from cultures.
All had IV pre- and postoperatively.
6-16 weeks Duration determined by monitoring clinical
course, osteomyelitis status, serial
magnetic resonance imaging (MRI) studies,
and serial erythrocyte sedimentation rate
(ESR) monitoring
Nakase et al (2006) All patients received appropriate IV
antibiotics pre- and postoperatively
— —
Patel et al (2014) — — Identified 4 predictors of failed medical
(pharmacotherapy) management with need
for surgical management: diabetes mellitus
(DM) (odds ratio [OR] 2.8, P ¼ .057);
C-reactive protein (CRP) > 115 (OR 4.7,
P ¼ .45); white blood cell count (WBC) >
12.5 (OR 3.3, P ¼ .045); and positive blood
cultures (OR 3.5, P ¼ .035). If patient had
none of 4: 8.3% failure risk; if 1/4 35.4%
failure; if 2/4: 40.2% failure risk; and 3-4:
76.9% failure risk.
Wang et al (2001) Ceftriaxone þ gentramycin; methic þ fusidin;
dicloxacillin þ/- rifampin depending on
sensitivities from cultures
— —
Wang et al (2012) Dicloxacillin predominantly used based on
sensitivities
— —
Yang et al (2016) RIPE: rifampicin (450 mg); isoniazid (INH)
(300 mg), pyrazinamide (1500 mg),
ethambutol (750 mg) and pyrazinamide
(1500 mg)/day
— —
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association between length of antibiotic treatment postoperative
and patient recovery.30 Later studies by Wang et al found similar
poor rates of recovery (20%) in patients with severe preoperative
neurological deficit presenting with SEA of the cervical, thoracic,
and/or lumbar spine. These reports showed isolated thoracic SEA
had no recovery versus 50% recovery rates in patients with iso-
lated lumbar SEA.40 Thalia et al further demonstrated that a
patient’s preoperative American Spinal Injury Association
(ASIA) motor score was a better predictor of postoperative ASIA
motor scores in comparison to antibiotic duration or preoperative
risk factors.29 Of the 6 thoracic patients included in the overall
study, 2 had improvement in ASIA motor score (1 by 1 point and 1
by 3 points) and 4 had no change at 3 months postoperation. At 12
months, 4 (67%) had improved ASIA motor scores.
Patel et al compared patients treated with antibiotics
alone (group 1), immediate surgery (laminectomy, anterior
discectomy and fusion, corpectomy, or posterior spinal instru-
mentation with fusion) and antibiotics based on severity and
location of SEA (group 2), or antibiotics followed by delayed
surgery with antibiotics due to treatment failure (group 3).
These studies found that 41% of patients treated with antibio-
tics alone failed to resolve the infection and eventually required
surgical intervention. Irrespective of surgical approach, all
patients treated surgically immediately had improvement in
ASIA motor score (mean improvement of 3.37 points). Patients
who failed medical management and required delayed surgical
intervention had significantly worse outcomes (lower motor
scores or increased pain postoperatively) compared with
patients treated with immediate antibiotics and surgery. Patel
et al also found that significant predictors of medical manage-
ment failure were a CRP level >115, a WBC count >12.5, and
blood cultures positive for bacteria (bacteremia).3 Similarly, de
la Fuente Aguado et al reported favorable outcomes in the 2
(66%) thoracic SEA cases treated with immediate laminectomy
compared with the 1 case (33%) that was treated with conser-
vative management and had a fatal outcome.24
Connor et al reported that surgical interventions were initi-
ated immediately whenever thoracic SEA cases presented with
acute motor strength loss.20 Patients treated with posterior
laminectomy had improved, stable, or worsening neurological
outcomes at follow-up in 79%, 8%, and 13% of cases, respec-
tively. Older age (P ¼ .04) and greater premorbid weakness
(P ¼ .012) were associated with worse postoperative outcome.
Furey et al analyzed data on 12 cases of thoracic SEAs treated
with either surgical decompression and evacuation for posterior
SEA or anterior decompression with structural allograft and
staged posterior instrumented fusion for anterior SEA. They
found no difference in outcome or survival between location
and surgical approach used.38 Risk factors associated with mor-
tality in this study were age >70 years (P ¼ .01), neurological
deficits present >5 days prior to surgery (P ¼ .04), a preopera-
tive ASIA D motor score (P ¼ .01), diabetes mellitus (DM;
P ¼ .01), MRSA sepsis (P ¼ .03), and end-stage renal disease
(ESRD; P ¼ .02).38 Of note, the authors were surprised by the
aforementioned increase in mortality associated with lower
presurgical ASIA D score. One potential explanation for this
could be delayed surgical intervention in patients with less
severe symptoms and subsequently worse outcomes associated
with the delay. Liem et al also found that patients with more
severe preoperative symptoms did better if rapid decompres-
sion occurred within 24 hours of symptoms compared with
patients who had delays in surgical decompression greater than
24 hours from time of onset. Of the 11 patients treated with
laminectomy and drainage (52%), 2 of them deteriorated and
required anterior corpectomy. The remaining 10 patients were
treated with transthoracic corpectomy and fixation (n ¼ 5;
24%), costotransversectomy (n ¼ 1; 5%), or percutaneous
aspiration (n ¼ 1; 5%). Patients with anterior pathology who
initially underwent laminectomy did poorly compared with
patients where the anterior lesion was approached directly from
an anterior approach. Development of sepsis (n ¼ 3; 14%)
during initial hospitalization was fatal in all cases and patients
Table 5. Decision-Marking Criteria.
Author (Year
Published) Decision-Making Criteria Used
Bostro¨m et al (2008) Abscesses located ventrally or dorsally were
treated with laminectomies. Abscesses
located dorsally were treated with
hemilaminectomies.
Connor et al (2013) Standard practice to operate when case
presents with acute motor strength loss or
bowel and/or bladder control (“surgical
emergency”).
Furey et al (2014) Decompression and evacuation for posterior
epidural abscesses with no structural
grafting. Anterior decompression with
structural allograft followed by a staged,
posterior instrumented fusion for anterior
located epidural abscess.
Hadjipavlou et al
(2000)
If primary epidural abscess was present
emergency laminectomy was performed. If
there was instability present in these cases,
posterior instrumentation and fusion was
recommended. If epidural abscess was
present secondary to spondylodiscitis and
the abscess was anteriorly located then
posterior instrumentation, deformity
correction, and fusion were recommended
in combination with anterior
decompression. In the case of posterior
abscesses secondary to spondylodiscitis,
again, emergent laminectomy, posterior
stabilization and fusion, and corrective
deformity was recommended in
combination with anterior decompression
and fusion.
Nakase et al (2006) Instrumentation and stabilization when
structural instability was present.
Patel et al (2014) Severity and location of the pathology dictated
treatment approach.
Yang et al (2016) Surgery was performed when erythrocyte
sedimentation rate decreased and
C-reactive protein was within normal range.
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who presented with worse neurological symptoms preoperative
had worse outcomes.26
No included articles compared surgical treatment
approach efficacy or specifically compared outcomes asso-
ciated with varied surgical approaches. As noted above,
Liem et al did find more favorable outcomes with a direct
approach compared with a posterior laminectomy in patients
with anterior thoracic SEAs; however, no major compari-
sons were made between other surgical techniques used for
posteriorly located abscesses, and post hoc analysis for ante-
rior approach was limited.
Discussion
Thoracic SEA is a serious and potentially life-threatening med-
ical emergency if left untreated. This systematic review com-
piled previously published studies to bridge gaps in relevant
clinical knowledge. To this aim, the authors included 25 arti-
cles and extracted information on outcomes and treatment of
thoracic SEA. Information from included articles was grouped
into 1 of 5 categories: (1) clinical presentation, duration of
symptoms, and risk factors; (2) radiological, microbiology, and
laboratory findings; (3) pharmacological management; (4) sur-
gical management; and (5) patient outcomes.
Surgical Management and Patient Outcomes
To our knowledge, no formalized guidelines exist for the treat-
ment of thoracic SEAs, specifically. Prior systematic reviews
on SEAs at all levels have compared treatment modalities by
spatial orientation around the spinal cord (anterior, posterior,
posteriolateral). However, these prior approaches have not
focused to any large extent on anatomical-specific outcomes
that are relevant to the thoracic spinal cord level specifically
(faster rate of cord compression, higher incidence of parapar-
esis/paraplegia compared with other levels, worse recovery
rates compared with other levels). Rather, treatment approach
in the majority of included cases involved 3 components: (1)
broad-spectrum empiric antibiotics after abscess biopsy, (2)
targeted antibiotics based on cultured sensitivity profiles for
the bacteria, and (3) surgical decompression þ/- instrumenta-
tion. Results from included studies further demonstrate that
patient outcomes between studies, even when presenting with
similar preoperative neurological deficits, are highly variable.
Heterogeneity in patient outcomes highlights the need to better
understand which approaches to surgical management of thor-
acic SEAs produce the best patient outcomes.
None of the included articles directly compared different
surgical approaches for treatment of thoracic SEAs. While
Liem et al found improved outcomes when anterior located
thoracic SEAs were treated using an anterior approach versus
a posterior laminectomy, no detailed comparisons were made
between outcomes associated with different surgical
approaches. Surgical complications were not compared
between the types of surgery. Results obtained from this sys-
tematic review underscore a need for randomized clinical
studies aimed at comparing efficacy of different surgical
approaches based on location of the abscess. It is important
to note that the included studies did not characterize the pre-
operative spinal stability or alignment (ie, in cases of osteo-
myelitis) well enough to make meaningful conclusions about
types of surgical intervention. However, from the literature
and in the authors’ experience, it is clear that reconstruction
with stabilization should be added in cases of spine instability
and kyphosis.
Results outlined in this systematic review can aid spine
surgeons in developing methodologies capable of addressing
our current gaps in knowledge. First, the majority of studies
included reported improved outcomes with immediate surgical
intervention and antibiotics,3,20,24,26,38 and as previously dis-
cussed, up to 55% of patients presenting with SEAs are initially
misdiagnosed with significant delays in treatment.9 Further-
more, as noted above, results presented by Hadiipavlou et al
and Abdelrahman et al on neurological deficits and neurologi-
cal recovery following spinal decompression for SEA, respec-
tively, demonstrated a significantly higher rate of paraplegia/
paraparesis prior to surgery and a significantly lower recovery
rate following surgical decompression in patients with SEAs at
the thoracic level compared with other levels.35,36 In light of
these findings, early diagnosis and aggressive surgical decom-
pression when neurological deficits are present is a reasonable
approach and can help reduce the greater likelihood of persis-
tent morbidity in this patient population. With that said, a large
degree of bias exists within the current literature regarding
patients included in published studies (more often sicker
patients with greater neurological deficit at time of admission).
This selection bias in patient population complicates external
validity to a less or nonneurologically impaired patient popu-
lation. Clinical judgement and vigilance obtained through rec-
ognition of characteristic signs and symptoms in addition to
laboratory and radiological findings can aid spine surgeons in
increasing speed of thoracic SEA diagnosis and management.
Second, risk factors associated with increased mortality (ASIA
D score, DM, MRSA sepsis, ESRD, age >70, and neurological
deficits present >5 days prior to surgery) can aid in the design
of surveillance programs for spine surgeons. For example,
patients with multiple risk factors for the development of a
thoracic SEA following spine surgery could be educated on
warning signs associated with development of thoracic SEAs
(back pain, fever, paraparesis, and other signs of neurological
deficit) with the goal of quicker diagnosis and surgical inter-
vention. Third, risk factors for medical management failure
could be adapted into an algorithm to predict medical man-
agement failure based on risk factors and presenting symp-
toms. This algorithm could stratify immediate surgical
management with medical management versus permissive
medical management alone in patients who are predicted to
have a low calculated predictive risk of medical management
failure based on a predetermined threshold. This would allow
spine surgeons to optimize treatment outcomes, while also
addressing the potential for unnecessary costs associated with
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surgical intervention among patients with low risk of medical
management alone failure.
Future studies with a larger sample size, greater statistical
power, and randomized controls could yield valuable data to
power statistical models capable of predicting which patients
are at greatest risk for developing thoracic SEAs, more likely to
fail medical management, and which surgical approaches are
most efficacious for thoracic SEAs accounting for approach
(anterior, posterior, anterolateral). While the execution of a
randomized controlled trial in this patient population is diffi-
cult, if not impossible, prospective comparative trials are cer-
tainly within the realm of possibility at tertiary centers.
Clinical Presentation and Duration of Symptoms
Recognizing signs and symptoms associated with the presence
of thoracic SEAs is essential for the initial diagnosis and sub-
sequent timely management. Despite characteristic patient pre-
sentation (back pain, fever, and neurological deficit),26,32 the
diagnosis of thoracic SEA is often missed and patients are not
adequately diagnosed during the initial encounter.9 One possi-
ble reason for the diagnostic error is primary care and emer-
gency medicine physicians reluctance to order expensive MRI
capable of visualizing abscess foci. In this case, physician edu-
cation would be essential for reducing diagnostic errors in
patients presenting with thoracic SEAs. Importantly, the dura-
tion of symptoms prior to time of admission can be quite vari-
able and a high level of suspicion is warranted, especially
among patients with relevant risk factors (intravenous drug use,
AIDS and immunocompromised, DM, and chronic renal fail-
ure). More controlled studies with larger patient cohorts would
afford researchers an adequate sample size (beta) for logistical
regression models capable of predicting adverse events of
interest (medical management failure, development of thoracic
SEA, patient mortality, etc). Additionally, a larger controlled
patient population would allow researchers to better character-
ize initial presenting symptoms (signs, symptoms, duration)
with a standardized data-collection protocol, rather than the
amalgam of varied research tools presented in this systematic
review. Finally, more specific recommendations on how long
to continue antibiotics after ESR/CRP laboratory values nor-
malize would provide clinicians more definitive guidance on
needed length of pharmacotherapy in patients presenting with
thoracic SEA.
Radiological, Laboratory, and Microbiology Findings
Aside from the initial patient history and physical, radiological
and laboratory findings are often the only other data points
available in guiding clinical decision making. CRP and ESR
are 2 commonly monitored inflammatory markers used before
and after surgical/antibiotics. CRP was nearly always elevated
in patients presenting with thoracic SEAs with levels decreas-
ing to baseline indicative of a successful treatment response.
Based on results of this review, all patients with suspected
thoracic SEA should undergo bloodwork to measure CRP,
ESR, and WBC. MRI with gadolinium contrast and/or CT
imaging with or without myelography were found to have high
sensitivity and specificity capable of determining treatment
response following antibiotics and surgical decompression.
As such, MRI and CT are reasonable initial diagnostic modal-
ities and can aid spine surgeons in localizing the thoracic
abscess within the epidural space. As mentioned above, future
studies aimed at comparing the efficacy between different
surgical techniques based on thoracic SEA location (anterior,
posterior, etc) will require a detailed knowledge of abscess
location prior to preparation for surgical approach. Further-
more, serial monitoring of ESR, CRP, WBC, and/or MRI/CT
has the potential to guide duration of antibiotic treatment.
This duration is important given the rise in antibiotic resis-
tance, antibiotic stewardship programs, and the cost associ-
ated with longer duration of unnecessary antibiotics following
SEA resolution.39-41 Most often infections of the thoracic
epidural space were caused by S aureus, although M tubercu-
losis, other coagulase negative Staphylococcus, gram nega-
tive rods, and mixed microbial infections are reported to a
lesser extent. With this in mind, empirical therapy following
thoracic SEA biopsy should include broad spectrum antibio-
tics normally used to cover the most commonly implicated
microorganisms (MSSA, MRSA, other coagulase negative
Staphylococcus species).
Pharmacological Management
Pharmacological therapy was based on cultures obtained from
thoracic SEA biopsy. Biopsy should be obtained prior to initia-
tion of pharmacotherapy rather than initiating broad spectrum
antibiotics before sample collection, as the latter can compro-
mise ability to culture aspirates and limits ability to obtain
bacterial sensitivity profiles for more tailored medical manage-
ment. Length of antibiotics for treatment of abscess varied by
study, but a number of reports monitored serial ESR and CRP
laboratory values to monitor infection response, with slower
responses requiring longer courses of antibiotic therapy.24,27
As mentioned above, with growing concern over antimicrobial
resistance exceeding our ability to produce novel antibiotics to
counter such resistance, it is important to protect our antimi-
crobial arsenal from unnecessary resistance caused by inap-
propriate antibiotic use.
Use of pharmacological therapy (medical management) was
ubiquitous across studies; however, the literature is largely
lacking in terms of comparison between medical management
alone for thoracic SEA, specifically, versus immediate surgical
intervention with focused antibiotic treatment. Importantly,
Patel et al reported rates as high as 41% for failure of antibiotic
therapy alone without combined surgery.3 Based on cases pre-
sented by Patel et al, patients who failed antibiotic therapy and
needed delayed surgery for treatment of abscess had a statisti-
cally significant worse outcomes compared with patients
treated immediately at admission with decompression (ie, irre-
versible neurological deficits). Future studies with a larger
patient population with thoracic SEAs is necessary to better
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characterize factors associated with failure of medical manage-
ment and subsequent risk of worsening neurological sequelae.
Limitations and Future Study
To address this clinical entity, investigators initially aimed to
further characterize thoracic SEAs based on presentation and
clinical workup. In addition, they aimed to discuss surgical
considerations, specifically, the importance of surgical and/or
medical management timing in relation to patient risk factors
and subsequent patient outcomes, general rates of neurological
recovery following immediate versus delayed surgical manage-
ment, and specific surgical approaches. However, several lim-
itations became evident during the systematic review process.
First, despite initial objectives, investigators soon found that
much of the past and current literature does not stratify patient
findings based on spinal cord level. As such, synthesis of
extracted data was limited. Second, the majority of articles
yielded from the initial database query process were simple
case reports and did not meet the eligibility criteria for inclu-
sion in this study. Our final smaller list of eligible articles
provided some invaluable information with regard to patient
risk factors, presentation, microorganisms involved, and
response to varied treatment approaches. Limited overlap
between content analyzed in each included article was less than
ideal for comparison between studies. However, despite limited
overlap in protocol and study focus, meaningful results capable
of informing clinical decision making were still able to be
extracted from included studies and discussed in the current
review. Third, because thoracic SEAs are a fairly rare clinical
entity seen at any one regional research center, enrolling
enough patients for randomized clinical trials or larger cohort
studies would be difficult and likely require a multicenter col-
laboration and multiple years of enrollment, data collection,
and analysis. Fourth, the majority of included articles did not
carry out any sort of exhaustive statistical analysis to identify
significance factors, odds ratios, group mean differences, and
other metrics useful in patient safety and quality improvement.
Last, external validity and generalizability is stymied, in part,
by a selection bias in favor of including patients with greater
neurological deficit rather than patients without significant
impairment at time of admission. Future studies involving a
greater degree of variance in patient population (age, present-
ing neurological status at time of admission, comorbid disease
history) as well as a greater sample size can further aid spine
surgeons in attaining improved outcomes in patients presenting
with thoracic SEA.
Conclusion
The present systematic review addresses a significant gap in
the field of spine research. For the first time researchers have
focused specifically on SEAs of the thoracic level, as opposed
to previously published general analysis of SEAs as a whole.
Given the fact that thoracic SEAs are quicker to progress and
compress vital cord structures, the combination of results
presented and relevant clinical experience can be used by spine
surgeons and other providers to reduce morbidity and mortality
in their patient populations. Based on the results, investigators
recommend early MRI imaging of the spine, laboratory workup
(ESR/CRP, complete blood count), abscess culture followed by
empiric antibiotics, and immediate surgical decompression
when neurological deficits are present.
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Author (Year
Published) Study Type
Number
of Patients
Total
Number of Patients
With Isolated
Thoracic Level
Abdelrahman et al
(2017)
Retrospective 600 27
Aryan et al (2007) Retrospective 15 2
Bostro¨m et al
(2008)
Retrospective 46 27
Chen et al (2004) Retrospective 17 3
Christodoulou et al
(2006)
Retrospective 12 8
Connor et al (2013) Retrospective 77 20
Curry et al (2005) Retrospective 48 7
Darouiche et al
(1992)
Retrospective 43 9
Davda et al (2014) Retrospective 34 16
de la Fuente
Aguado et al
(1992)
Retrospective 4 3
Del Curling et al
(1990)
Retrospective 29 6
Dzupova et al
(2017)
Retrospective 54 14
Furey et al (2014) Retrospective 42 12
Hadjipavlou et al
(2000)
Retrospective 101 11
Kuker et al (1997) Retrospective 13 6
Lee et al (2011) Retrospective 31 22
Liem et al (1994) Retrospective 21 21
Nakase et al (2006) Retrospective 9 4
Patel et al (2014) Retrospective 128 50
Redekop et al
(1992)
Retrospective 25 7
Talia et al (2015) Retrospective 9 6
Wang et al (2001) Retrospective 19 9
Wang et al (2012) Prospective 102 12
Wong et al (1998) Retrospective 7 3
Yang et al (2016) Retrospective 31 27
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